Smorgon Steel Shareholders Approve Deal with OneSteel and BlueScope Steel

Smorgon Steel shareholders have today overwhelmingly voted in favour of the Smorgon Steel Scheme of Arrangement which, subject to approval being granted by the Supreme Court of Victoria, will result in all Smorgon Steel shares being acquired by OneSteel Limited and the Smorgon Steel Distribution Businesses being acquired by BlueScope Steel Limited.

Two separate class meetings of shareholders were held; a BlueScope Steel Class Meeting and an Eligible SSX Shareholders Meeting.

Smorgon Steel shareholders have today overwhelmingly voted in favour of the Smorgon Steel Scheme of Arrangement which, subject to approval being granted by the Supreme Court of Victoria, will result in all Smorgon Steel shares being acquired by OneSteel Limited and the Smorgon Steel Distribution Businesses being acquired by BlueScope Steel Limited.

Two separate class meetings of shareholders were held; a BlueScope Steel Class Meeting and an Eligible SSX Shareholders Meeting.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    InfraBuild. (2019, March 18). Smorgon Steel Shareholders Approve Deal with OneSteel and BlueScope Steel. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=9476.

  • MLA

    InfraBuild. "Smorgon Steel Shareholders Approve Deal with OneSteel and BlueScope Steel". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=9476>.

  • Chicago

    InfraBuild. "Smorgon Steel Shareholders Approve Deal with OneSteel and BlueScope Steel". AZoM. https://www.azom.com/news.aspx?newsID=9476. (accessed November 21, 2024).

  • Harvard

    InfraBuild. 2019. Smorgon Steel Shareholders Approve Deal with OneSteel and BlueScope Steel. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=9476.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.